Julie holds a PhD in Neuroscience with 15 years’ experience in academic and industrial research.

Julie obtained her PhD in Neuroscience in 2009 in Montpellier, France. Her first research work focused on the antidepressant effects of an inhibitor of neurosteroid synthesis. As a specialist in behavioral neurobiology, she conducted several research projects aiming to understand the cellular mechanism involved in memory deficits related to neurogenerative and neuropsychiatric disorders.
In 2010 Julie received the Brain & Behavior Research Foundation NARSAD Young Investigator Grant to fund her research at the University of Pennsylvania, Philadelphia, USA about mechanisms of major depressive disorders. Together with Dr Berton and Dr Beck, she implemented state-of-the-art optogenetic techniques combining electrophysiology and brain imaging. Next, she extended her research to Parkinson’s disease and developed tools and methods to dissect, isolate, visualize and modulate neural network of basal ganglia whose failure is the cause of motor dysfunctions in the disease.
In 2012, back to France, Julie pursued her career in applied neuroscience research. She joined the CRO Histalim, Montpellier, France, specialized in tissues imaging and analysis, which is now a subsidiary of Cerba Healthcare. She managed several GLP pre-clinical and regulatory toxicology studies being parts of Investigational Medicinal Product Dossier for clinical trial authorization. In 2018, Julie was hired as Project leader and quality & safety manager by CRO Amylgen, Montpellier, France, developing rodent models of ageing and of psychiatric and neurodegenerative pathologies.
Julie is a strongly dedicated scientist with a significant experience in several fields of neurosciences and brain diseases. She masters a large range of rodent models that cover all these diseases. Thanks to her career in CROs, Julie developed a high level of rigor and an ability to work in a high standard quality environment as required by GLP studies, which is essential to develop a top level R&D programs. Her sense of teamwork, scientific curiosity and critical-thinking skill makes her an invaluable asset for NERVOSAVE.